Efficient Generation of Pancreas/Duodenum Homeobox Protein 1+ Posterior Foregut/Pancreatic Progenitors from hPSCs in Adhesion Cultures
March 27th, 2019
Here, we present a detailed protocol to differentiate human pluripotent stem cells (hPSCs) into pancreas/duodenum homeobox protein 1+ (PDX1+) cells for the generation of pancreatic lineages based on the non-colony type monolayer growth of dissociated single cells. This method is suitable for producing homogenous hPSC-derived cells, genetic manipulation and screening.
Overview
This article presents a protocol for differentiating human pluripotent stem cells (hPSCs) into PDX1+ cells, facilitating the generation of pancreatic lineages. The method emphasizes non-colony type monolayer growth of dissociated single cells, ensuring homogeneity in the derived cells.
Key Study Components
Area of Science
- Stem Cell Biology
- Cell Differentiation
- Pancreatic Development
Background
- Human pluripotent stem cells (hPSCs) have potential for regenerative medicine.
- PDX1 is a crucial marker for pancreatic lineage specification.
- Traditional methods often yield heterogeneous cell populations.
- This protocol aims to improve the consistency of hPSC-derived cells.
Purpose of Study
- To develop a reliable method for generating PDX1+ pancreatic cells from hPSCs.
- To facilitate genetic manipulation and screening of derived cells.
- To enhance the understanding of pancreatic development from stem cells.
Methods Used
- Preparation of a basement membrane matrix for cell culture.
- Dispersion of cells for uniform stimulation.
- Use of RPMI 1640 medium for cell growth.
- Application of a non-colony type monolayer growth technique.
Main Results
- Successful differentiation of hPSCs into PDX1+ cells.
- Homogeneous population of pancreatic lineage cells achieved.
- Protocol allows for effective genetic manipulation.
- Demonstrated potential for further screening applications.
Conclusions
- The presented protocol is a significant advancement in stem cell research.
- It provides a reliable method for generating pancreatic cells.
- This approach may enhance future studies in pancreatic biology.
Frequently Asked Questions
Executive Industry Relevance
Generating homogeneous PDX1+ pancreatic progenitors from hPSCs addresses a key bottleneck in diabetes regenerative medicine and disease modeling. By initiating differentiation from dissociated single cells, this protocol reduces lineage heterogeneity and improves reproducibility across hPSC lines. Enhanced consistency supports reliable target validation and preclinical assay development for pancreatic therapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of pancreatic lineage specification using a defined PDX1+ progenitor population.
- Operational Value: Reduces variability in downstream target engagement assays by providing uniform cell inputs.
Screening & Assay Development
- Scientific Value: Produces a reproducible monolayer system suitable for high-content imaging of endocrine differentiation.
- Operational Value: Facilitates assay standardization through consistent cell attachment and stimulation in adhesion culture.
Translational & Preclinical Research
- Scientific Value: Supports mechanistic de-risking by recapitulating foregut patterning markers (SOX17, HNF1B, HNF4A) prior to PDX1 induction.
- Operational Value: Enables scalable expansion of pancreatic progenitors for preclinical efficacy and safety studies.
Pipeline & Workflow Integration
The method fits within the early discovery continuum, linking definitive endoderm formation to pancreatic progenitor generation for target and pathway validation.
- Discovery Biology: Supports hypothesis testing of pancreatic transcription factor networks via synchronized PDX1+ induction.
- Screening: Delivers quantitative, reproducible outputs for compound screening on pancreatic lineage commitment.
- Analytics: Enables stage-specific marker quantification (SOX17, HNF1B, HNF4A, PDX1) to assess differentiation efficiency.
- Translational Research: Provides a disease-relevant system for modeling monogenic diabetes and pancreatic agenesis.
- Enterprise Reuse: Defined adhesion culture format allows reuse across multiple hPSC lines and gene-edited backgrounds.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in pancreatic lineage commitment through marker-coexpression analysis (SOX17+/FOXA2+, PDX1+).
- Operational Value: Standardized dissociation and replating protocol minimizes batch effects in stem cell differentiation.
- Strategic Value: De-risks investment in pancreatic stem cell therapies by improving progenitor yield and consistency.
- Portfolio Impact: Enables risk-adjusted prioritization of hPSC lines based on differentiation competence into foregut progenitors.
Implementation Considerations
- Requires expertise in hPSC culture, dissociation techniques, and stage-specific medium formulation.
- Dependent on basement membrane matrix preparation and timed medium exchanges for germ layer progression.
- Necessitates standardized quantification methods (flow cytometry, immunostaining) for SOX17, PDX1, and foregut markers.
- Adaptation considerations include varying dissociation efficiencies across hPSC lines and matrix lot-to-matrix variability.
- Practical limitations include the need for sterile, temperature-controlled handling during matrix coating and cell seeding steps.
Biopharma FAQs
Chapters in this video
0:04
Title
0:28
Prepare Basement Membrane Matrix-coated Plates
1:15
Seed the hPSCs and Initiate Differentiation to Definitive Endoderm
3:57
Induce the Differentiation into Definitive Endoderm
5:13
Induce the Differentiation into the Primitive Gut Tube
5:47
Induce the Differentiation into PDX1+ Cells
6:28
Results: Analysis of hPSCs and the Generated Pancreas/Duodenum Homeobox Protein 1+ Posterior Foregut/Pancreatic Progenitors
8:06
Conclusion
